A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

NCT00834457 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

AIDS-related Kaposi's Sarcoma

Interventions

DRUG: abacavir/3TC/zidovudine
DRUG: abacavir /3TC plus ritonavir boosted lopinavir

Sponsor

Parirenyatwa Hospital

Collaborators

[object Object]
[object Object]
[object Object]